The University of Southampton
University of Southampton Institutional Repository

Report from the european myeloma network on interphase FISH in multiple myeloma and related disorders

Report from the european myeloma network on interphase FISH in multiple myeloma and related disorders
Report from the european myeloma network on interphase FISH in multiple myeloma and related disorders
The European Myeloma Network has organized two workshops on fluorescence in situ hybridization in multiple myeloma. The first aimed to identify specific indications and consensus technical approaches of current practice. A second workshop followed a quality control exercise in which 21 laboratories analysed diagnostic cases of purified plasma cells for recurrent abnormalities. The summary report was discussed at the EHA Myeloma Scientific Working Group Meeting 2010. During the quality control exercise there was acceptable agreement on more than 1000 tests. The conclusions from the collaboration were that the primary clinical applications for FISH analysis were for newly diagnosed cases of MM or frank relapse cases. A range of technical recommendations included: 1) Material should be part of the first draw of the aspirate; 2) Samples should be sent at suitable times that allow for the lengthy processing; 3) Most importantly PCs must be purified or specifically identified; 4) Positive cut-off levels should be the relatively conservative, 10% for fusion or break-apart probes and 20% for numerical abnormalities; 5) Informative probes should be combined to best effect; 6) In specialist laboratories a single experienced analyst is considered adequate; 7) At least 100 PC should be scored; 8) Essential abnormalities to test for are t(4;14), t(14;16) and 17p13 deletions; 9) Suitable commercial probes are available for clinically relevant abnormalities; 10) The clinical report should be expressed clearly and must state the percentage of PC involved and method used for identification; 11) A retrospective European based FISH data bank linked to clinical data should be generated and 12) Prospective analysis should be centralized for upcoming trials based on the recommendations. EMN aims to build on these recommendations to establish standards for a common European database to define subgroups with prognostic significance.
multiple myeloma, cytogenetics and molecular genetics, laboratory hematology
0390-6078
1272-1277
Ross, Fiona
ec0958f8-b992-4e4a-b7e3-c474600390ba
Avet-Loiseau, Herve
79aaa5c8-88a0-492d-a331-a141435c8ae0
Ameye, Genevieve
d5aa23ea-d9a7-46a0-9197-fb5c00a402a0
Gutierrez, Norma C.
ef63fa20-a175-4f32-8c4a-3d2b750034e0
Liebisch, Peter
8994826e-6015-47ec-b87d-280da8028c5d
O'Connor, Sheila
0e44e80c-6142-422c-92fa-c13203f37951
Dalva, Klara
9d9ccd4d-5a33-431d-9956-90d129c4c942
Fabris, Sonia
f0df7c26-91d9-4148-8902-0ca83cd04265
Testi, Adele M.
4010513c-d4fe-43e9-b5ba-0a8140faf867
Jarosova, Marie
db057718-9e90-4b95-a876-fb9e7c70c56c
Collin, Anna
7764d59b-d5eb-4b4c-beae-f31b3d7c378c
Kerndrup, Gitte
748e4646-0d9c-444f-8530-f4b327134f47
Kuglik, Petr
702f2cd2-ee00-417e-b4fa-c79d795e24c2
Ladon, Dariusz
4fb23642-564e-4228-9478-f332a1834c59
Bernasconi, Paolo
f320d07a-207c-4a95-baca-04db17a02641
Maes, Brigitte
a140774a-4e0c-44de-af0c-e51f477369ee
Zemanova, Zuzana
fb740b33-819e-4b4e-ba14-261e1ff61c8c
Michalova, Kyra
cb3f9859-72c1-4ab6-8429-399a5acbce60
Michaux, Lucienne
40729cf4-3457-480b-a30d-1b08f686d92d
Neben, Kai
348540f7-a0da-4302-a28d-7aa0824cf824
Hermansen, Niels Emil U.
e741e51c-f716-45fa-934a-3f8f57b8b22e
Rack, Katrina
2e74ecca-9991-4b76-819d-98db9361e9d6
Rocci, Alberto
7b64378b-37fa-4b1f-88ca-27016708659b
Protheroe, Rebecca
b2c9973f-ccf1-44a4-8e37-e76ee7e8ec0b
Chiecchio, Laura
3d2f63e3-3df1-4655-8478-00ecd89d009c
Poirel, Helene A.
165c77e3-a607-4a31-8d5b-9a43e2658c57
Sonneveld, Pieter
80d2c1ed-b2f8-4e26-aaaa-6ba42fff0744
Nyegaard, Mette
e51ca490-5801-4377-a397-44222652c402
Johnsen, Hans E.
93b510c2-7fa9-433a-bb5f-bdf9d248d57e
Ross, Fiona
ec0958f8-b992-4e4a-b7e3-c474600390ba
Avet-Loiseau, Herve
79aaa5c8-88a0-492d-a331-a141435c8ae0
Ameye, Genevieve
d5aa23ea-d9a7-46a0-9197-fb5c00a402a0
Gutierrez, Norma C.
ef63fa20-a175-4f32-8c4a-3d2b750034e0
Liebisch, Peter
8994826e-6015-47ec-b87d-280da8028c5d
O'Connor, Sheila
0e44e80c-6142-422c-92fa-c13203f37951
Dalva, Klara
9d9ccd4d-5a33-431d-9956-90d129c4c942
Fabris, Sonia
f0df7c26-91d9-4148-8902-0ca83cd04265
Testi, Adele M.
4010513c-d4fe-43e9-b5ba-0a8140faf867
Jarosova, Marie
db057718-9e90-4b95-a876-fb9e7c70c56c
Collin, Anna
7764d59b-d5eb-4b4c-beae-f31b3d7c378c
Kerndrup, Gitte
748e4646-0d9c-444f-8530-f4b327134f47
Kuglik, Petr
702f2cd2-ee00-417e-b4fa-c79d795e24c2
Ladon, Dariusz
4fb23642-564e-4228-9478-f332a1834c59
Bernasconi, Paolo
f320d07a-207c-4a95-baca-04db17a02641
Maes, Brigitte
a140774a-4e0c-44de-af0c-e51f477369ee
Zemanova, Zuzana
fb740b33-819e-4b4e-ba14-261e1ff61c8c
Michalova, Kyra
cb3f9859-72c1-4ab6-8429-399a5acbce60
Michaux, Lucienne
40729cf4-3457-480b-a30d-1b08f686d92d
Neben, Kai
348540f7-a0da-4302-a28d-7aa0824cf824
Hermansen, Niels Emil U.
e741e51c-f716-45fa-934a-3f8f57b8b22e
Rack, Katrina
2e74ecca-9991-4b76-819d-98db9361e9d6
Rocci, Alberto
7b64378b-37fa-4b1f-88ca-27016708659b
Protheroe, Rebecca
b2c9973f-ccf1-44a4-8e37-e76ee7e8ec0b
Chiecchio, Laura
3d2f63e3-3df1-4655-8478-00ecd89d009c
Poirel, Helene A.
165c77e3-a607-4a31-8d5b-9a43e2658c57
Sonneveld, Pieter
80d2c1ed-b2f8-4e26-aaaa-6ba42fff0744
Nyegaard, Mette
e51ca490-5801-4377-a397-44222652c402
Johnsen, Hans E.
93b510c2-7fa9-433a-bb5f-bdf9d248d57e

Ross, Fiona, Avet-Loiseau, Herve, Ameye, Genevieve, Gutierrez, Norma C., Liebisch, Peter, O'Connor, Sheila, Dalva, Klara, Fabris, Sonia, Testi, Adele M., Jarosova, Marie, Collin, Anna, Kerndrup, Gitte, Kuglik, Petr, Ladon, Dariusz, Bernasconi, Paolo, Maes, Brigitte, Zemanova, Zuzana, Michalova, Kyra, Michaux, Lucienne, Neben, Kai, Hermansen, Niels Emil U., Rack, Katrina, Rocci, Alberto, Protheroe, Rebecca, Chiecchio, Laura, Poirel, Helene A., Sonneveld, Pieter, Nyegaard, Mette and Johnsen, Hans E. (2012) Report from the european myeloma network on interphase FISH in multiple myeloma and related disorders. Haematologica, 97 (8), 1272-1277. (doi:10.3324/haematol.2011.056176). (PMID:22371180)

Record type: Article

Abstract

The European Myeloma Network has organized two workshops on fluorescence in situ hybridization in multiple myeloma. The first aimed to identify specific indications and consensus technical approaches of current practice. A second workshop followed a quality control exercise in which 21 laboratories analysed diagnostic cases of purified plasma cells for recurrent abnormalities. The summary report was discussed at the EHA Myeloma Scientific Working Group Meeting 2010. During the quality control exercise there was acceptable agreement on more than 1000 tests. The conclusions from the collaboration were that the primary clinical applications for FISH analysis were for newly diagnosed cases of MM or frank relapse cases. A range of technical recommendations included: 1) Material should be part of the first draw of the aspirate; 2) Samples should be sent at suitable times that allow for the lengthy processing; 3) Most importantly PCs must be purified or specifically identified; 4) Positive cut-off levels should be the relatively conservative, 10% for fusion or break-apart probes and 20% for numerical abnormalities; 5) Informative probes should be combined to best effect; 6) In specialist laboratories a single experienced analyst is considered adequate; 7) At least 100 PC should be scored; 8) Essential abnormalities to test for are t(4;14), t(14;16) and 17p13 deletions; 9) Suitable commercial probes are available for clinically relevant abnormalities; 10) The clinical report should be expressed clearly and must state the percentage of PC involved and method used for identification; 11) A retrospective European based FISH data bank linked to clinical data should be generated and 12) Prospective analysis should be centralized for upcoming trials based on the recommendations. EMN aims to build on these recommendations to establish standards for a common European database to define subgroups with prognostic significance.

This record has no associated files available for download.

More information

e-pub ahead of print date: 27 February 2012
Published date: 2012
Keywords: multiple myeloma, cytogenetics and molecular genetics, laboratory hematology
Organisations: Human Development & Health

Identifiers

Local EPrints ID: 337678
URI: http://eprints.soton.ac.uk/id/eprint/337678
ISSN: 0390-6078
PURE UUID: e1ea2268-b6b9-47a8-ac58-0786728c79e1

Catalogue record

Date deposited: 02 May 2012 11:08
Last modified: 14 Mar 2024 10:57

Export record

Altmetrics

Contributors

Author: Fiona Ross
Author: Herve Avet-Loiseau
Author: Genevieve Ameye
Author: Norma C. Gutierrez
Author: Peter Liebisch
Author: Sheila O'Connor
Author: Klara Dalva
Author: Sonia Fabris
Author: Adele M. Testi
Author: Marie Jarosova
Author: Anna Collin
Author: Gitte Kerndrup
Author: Petr Kuglik
Author: Dariusz Ladon
Author: Paolo Bernasconi
Author: Brigitte Maes
Author: Zuzana Zemanova
Author: Kyra Michalova
Author: Lucienne Michaux
Author: Kai Neben
Author: Niels Emil U. Hermansen
Author: Katrina Rack
Author: Alberto Rocci
Author: Rebecca Protheroe
Author: Laura Chiecchio
Author: Helene A. Poirel
Author: Pieter Sonneveld
Author: Mette Nyegaard
Author: Hans E. Johnsen

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×